Advisor Partners LLC Biogen Inc. Transaction History

Advisor Partners LLC

$1.42 Billion
Q2 2022

A detailed history of Advisor Partners LLC transactions in Biogen Inc. stock. As of the latest transaction made, Advisor Partners LLC holds 2,653 shares of BIIB stock, worth $535,375. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,653

Previous 1,820 45.77%

Holding current value

$535,375

Previous $383,000 41.25%

% of portfolio

0.04%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $156,220 - $185,775	833 Added 45.77%	2,653 $541,000
Q1 2022 Apr 27, 2022	SELL	$193.77 - $244.14 $318,751 - $401,610	-1,645 Reduced 47.47%	1,820 $383,000
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $150,698 - $193,669	-673 Reduced 16.26%	3,465 $832,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $104,140 - $135,810	-368 Reduced 8.17%	4,138 $1.17 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $19,166 - $30,688	-74 Reduced 1.62%	4,506 $1.56 Million
Q1 2021 Jun 01, 2021	SELL	$242.95 - $284.63 $89,162 - $104,459	-367 Reduced 7.42%	4,580 $1.28 Million
Q4 2020 Feb 17, 2021	SELL	$236.26 - $355.63 $567,496 - $854,223	-2,402 Reduced 32.68%	4,947 $1.21 Million
Q3 2020 Nov 19, 2020	SELL	$264.77 - $305.71 $7,943 - $9,171	-30 Reduced 0.41%	7,349 $2.09 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $410,234 - $543,284	-1,586 Reduced 17.69%	7,379 $1.97 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $624,538 - $792,235	2,323 Added 34.97%	8,965 $2.84 Million
Q4 2019 Jan 24, 2020	BUY	$220.06 - $304.07 $104,308 - $144,129	474 Added 7.68%	6,642 $1.95 Million
Q3 2019 Oct 16, 2019	BUY	$217.44 - $243.88 $231,791 - $259,976	1,066 Added 20.89%	6,168 $1.44 Million
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $105,259 - $116,025	480 Added 10.39%	5,102 $1.19 Million
Q1 2019 Apr 23, 2019	SELL	$216.71 - $338.96 $358,438 - $560,639	-1,654 Reduced 26.35%	4,622 $1.09 Million
Q4 2018 Jan 29, 2019	BUY	$278.5 - $352.75 $186,873 - $236,695	671 Added 11.97%	6,276 $1.89 Million
Q3 2018 Nov 06, 2018	BUY	$293.51 - $383.83 $57,234 - $74,846	195 Added 3.6%	5,605 $1.98 Million
Q2 2018 Jul 25, 2018	BUY	$257.52 - $306.91 $224,299 - $267,318	871 Added 19.19%	5,410 $1.57 Million
Q1 2018 May 03, 2018	SELL	$260.13 - $367.91 $200,039 - $282,922	-769 Reduced 14.49%	4,539 $1.24 Million
Q4 2017 Jan 26, 2018	BUY	$307.64 - $344.58 $163,356 - $182,971	531 Added 11.12%	5,308 $1.82 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $1.34 Million - $1.57 Million	4,777	4,777 $1.5 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Account

Advisor Partners LLC Biogen Inc. Transaction History